MACROGENICS, INC.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $32.8M | $20.8M | $56.6M | $72.8M | $6.9M | $13.2M | $19.4M | $110.7M |
| Cost of Revenue | — | — | $0 | $0 | $0 | $0 | $233.0K | $168.0K |
| Gross Profit | — | — | $56.6M | $72.8M | $6.9M | $13.2M | $19.1M | $110.5M |
| Gross Margin | — | — | 100.0% | 100.0% | 100.0% | 100.0% | 98.8% | 99.8% |
| Operating Expenses | ||||||||
| Research & Development | $38.8M | $35.0M | $34.0M | $32.7M | $40.8M | $39.7M | $38.9M | $40.5M |
| SG&A Expense | $7.9M | $9.7M | $9.2M | $9.9M | $9.3M | $10.7M | $27.8M | $14.1M |
| Operating Income | $-13.9M | $-33.4M | $-5.6M | $18.6M | $-43.2M | $-42.6M | $-52.8M | $54.2M |
| Operating Margin | -42.2% | -161.0% | -9.9% | 25.6% | -629.3% | -323.1% | -273.0% | 48.9% |
| Interest Expense | $4.4M | $4.9M | — | $3.3M | $802.0K | $91.0K | $-24.0K | $0 |
| Pretax Income | $-69.6M | — | — | $16.8M | $-42.6M | — | — | $56.3M |
| Income Tax Expense | $0 | — | — | $0 | $105.0K | — | — | $0 |
| Net Income | $19.5M | $-36.8M | $-14.2M | $16.8M | $-36.3M | $-41.0M | $-15.4M | $56.3M |
| Net Margin | 59.4% | -177.0% | -25.0% | 23.1% | -527.7% | -311.1% | -79.7% | 50.9% |
| EPS (Basic) | $0.31 | $-0.58 | $-0.23 | $0.27 | $-0.57 | $-0.65 | $-0.24 | $0.90 |
| EPS (Diluted) | $0.31 | $-0.58 | $-0.23 | $0.27 | $-0.57 | $-0.65 | $-0.24 | $0.90 |
| Shares Outstanding (Basic) | 63.6M | 63.4M | 63.2M | 63.2M | 63.1M | 63.0M | 62.6M | 62.7M |
| Shares Outstanding (Diluted) | 63.6M | 63.4M | 63.2M | 63.3M | 63.1M | 63.0M | 62.6M | 62.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |